Wei Fu
Chairman chez EVEREST MEDICINES LIMITED
Fortune : 67 M $ au 31/03/2024
Profil
M. Wei Fu est un directeur indépendant d'I-Mab, un président d'Everest Medicines Ltd, un directeur général de Shanghai Kangshiqiao Business Consulting Co. Ltd, président-directeur général et associé directeur général de C-Bridge Capital Investment Management Ltd. et président-directeur général de Cbc Group Co. Ltd. Il siège au conseil d'administration de I-Mab, Ascletis Biopharmaceutical (Hangzhou) Co. Ltd, Everest Medicines (Singapore) Pte Ltd, Everest Medicines II BVI Ltd, Everest Medicines II HK Ltd, Everest Medicines II Ltd, Everonc Medicines Ltd et Everonc Medicines, Inc. M. Fu a précédemment occupé les postes de directeur général du département des investissements de Far East Horizon Ltd, de responsable de Beijing de Themes Investment Management Ltd, de directeur associé du département des capitaux privés de Standard Chartered Business Consulting Beijing Co. Ltd. et directeur non exécutif chez Ascletis Pharma, Inc. Il a obtenu son diplôme de premier cycle à l'université technologique de Nanyang.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EVEREST MEDICINES LTD.
6,92% | 12/03/2024 | 22 425 617 ( 6,92% ) | 67 M $ | 31/03/2024 |
Postes actifs de Wei Fu
| Sociétés | Poste | Début |
|---|---|---|
| I-MAB | Director/Board Member | 01/06/2018 |
| EVEREST MEDICINES LIMITED | Chairman | 01/07/2017 |
CBC Group (Singapore) Pte. Ltd.
 CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group (Singapore) Pte. Ltd.(CBC Group) is a private equity firm founded in 2014 by Wei Fu. The firm is headquartered in Singapore with additional offices in New York, Hong Kong, Shanghai and Beijing and is wholly owned by CBC Group Investment Management Ltd. | Chief Executive Officer | 01/01/2014 |
| Everest Medicines (Singapore) Pte Ltd. | Director/Board Member | - |
AffaMed Therapeutics
 AffaMed Therapeutics Pharmaceuticals: MajorHealth Technology AffaMed Therapeutics is a Chinese company focused on providing innovative treatments to patients. The company is based in Shanghai, CN. The company's mission and vision are centered around improving patient access to these treatments. The company has a pipeline of products in development to achieve this goal. and has subsidiaries in United States and Hong Kong. The CEO of the company is Dayao Zhao. | Chairman | - |
Affamed Therapeutics (Us), Inc.
 Affamed Therapeutics (Us), Inc. Pharmaceuticals: MajorHealth Technology Part of AffaMed Therapeutics, Affamed Therapeutics (US), Inc. is a clinical stage biopharmaceutical company based in New York, NY. The private company focuses on developing and commercializing pharmaceutical, digital, and surgical products to address critical unmet medical needs in ophthalmological, neurological, and psychiatric disorders for patients worldwide. The CEO of the company is Dayao Zhao. | Director/Board Member | - |
| Everest Medicines II BVI Ltd. | Director/Board Member | - |
| Everest Medicines II HK Ltd. | Director/Board Member | - |
| Everonc Medicines, Inc. | Director/Board Member | - |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░ ░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Anciens postes connus de Wei Fu
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Wei Fu
| Nanyang Technological University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| FAR EAST HORIZON LIMITED | Finance |
| HUGEL, INC. | Health Technology |
| EVEREST MEDICINES LIMITED | Health Technology |
| ASCLETIS PHARMA INC. | Health Technology |
| I-MAB | Health Technology |
| Entreprise privées | 15 |
|---|---|
Themes Investment Management Ltd.
 Themes Investment Management Ltd. Investment ManagersFinance Themes Investment Management Ltd is a private equity firm founded in 2009. The firm is headquartered in Hong Kong. | Finance |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Health Technology |
CBC Group (Singapore) Pte. Ltd.
CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group (Singapore) Pte. Ltd.(CBC Group) is a private equity firm founded in 2014 by Wei Fu. The firm is headquartered in Singapore with additional offices in New York, Hong Kong, Shanghai and Beijing and is wholly owned by CBC Group Investment Management Ltd. | Finance |
| CBC Group Co., Ltd. | |
AffaMed Therapeutics
AffaMed Therapeutics Pharmaceuticals: MajorHealth Technology AffaMed Therapeutics is a Chinese company focused on providing innovative treatments to patients. The company is based in Shanghai, CN. The company's mission and vision are centered around improving patient access to these treatments. The company has a pipeline of products in development to achieve this goal. and has subsidiaries in United States and Hong Kong. The CEO of the company is Dayao Zhao. | Health Technology |
| C-Bridge Capital Investment Management Ltd. | |
| Standard Chartered Business Consulting Beijing Co. Ltd. | |
Everest Medicines II Ltd.
 Everest Medicines II Ltd. Pharmaceuticals: MajorHealth Technology Everest Medicines II Ltd. develops and commercializes pharmaceutical products. The private company is based in Road Town, Cayman Islands. | Health Technology |
| Everest Medicines II HK Ltd. | |
| Everest Medicines (Singapore) Pte Ltd. | |
| Everonc Medicines Ltd. | |
| Everonc Medicines, Inc. | |
| Everest Medicines II BVI Ltd. | |
Affamed Therapeutics (Us), Inc.
Affamed Therapeutics (Us), Inc. Pharmaceuticals: MajorHealth Technology Part of AffaMed Therapeutics, Affamed Therapeutics (US), Inc. is a clinical stage biopharmaceutical company based in New York, NY. The private company focuses on developing and commercializing pharmaceutical, digital, and surgical products to address critical unmet medical needs in ophthalmological, neurological, and psychiatric disorders for patients worldwide. The CEO of the company is Dayao Zhao. | Health Technology |
C-Bridge Capital GP IV Ltd.
 C-Bridge Capital GP IV Ltd. Financial ConglomeratesFinance Part of CBC Group Investment Management Ltd., C-Bridge Capital GP IV Ltd. provides investment services. | Finance |
